agitg trial news

AGITG Trial News

AGITG Trial news: The AGITG currently has fifteen studies open to recruitment and three studies in follow up.

The table below details the AGITG trials that are currently accruing patients.

Recruited Target Recruitment Period (months) Date of First Site Open (ANZ) Number of Sites Open 
ACTICCA-1 25 40 36 25 July 2016 13
ASCOLT 441 460 48 18 June 2014 32
ASCOLT – Global 1537 1587
DYNAMIC-III 405 1000 54 09 October 2017 41
DYNAMIC-Pancreas 46 438 54 01 March 2019 23
DYNAMIC-Rectal 168 408 36 18 June 2018 36
FORECAST-1 2 30 12 11 September 2020 1
INTEGRATE II 73 90 48 19 October 2016 27
INTEGRATE II – Global 208 350 63
MASTERPLAN 6 120 48 01 October 2019 7
MONARCC 25 80 24 20 June 2018 22
NABNEC 41 58 54 15 September 2016 17
Neo-CREATE 8 20 36 17 June 2019 4
PALEO 5 54 36 16 September 2019 1
RENO 24 250 36 21 January 2019 7
SPAR 66 222 48 13 April 2018 15
TOP GEAR 237 280 118 29 September 2009 27
TOP GEAR – Global 547 570 41

Recruitment figures are for Australian and New Zealand sites as at end September 2020.

Trial Results Lay Summaries (click on the links below): 
ABC
Adjuvant GIST/ EORTC 62024
Advanced GIST
AG9601
A La CaRT
ATTACHE
ATTAX-3
CO.17
CO.23
ESPAC-3
GAP
ICECREAM
INTEGRATE
MAX
NSABP CO-7
PAN 1
REGISTER
SCOT
TACTIC
TOP GEAR
TROG 01.04 / IG0103R

Share